Geneius Biotechnology is developing T cells as a quasi-personalized, off-the-shelf, therapy and preventive measure against COVID-19.
A summary of daily biopharma industry news regarding the novel coronavirus trending on March 27, 2020, with the FDA now working with 220 test developers.
Human antibodies made in genetically engineered cows have proved safe in an early-stage clinical trial.
Anyone who goes down with flu in Europe this winter could be asked to enroll in a randomized clinical trial in which they will either be given a drug, which may or may not work, or standard advice to take bed rest and paracetamol. Those who agree could be helping the world prepare for the […]
In recent weeks, the threat to South Korea from Middle East Respiratory Syndrome, better known as MERS, has exploded. Over the last 18 months or so, Ebola has hit West Africa hard and penetrated the borders of the United States and Europe. During the previous decade, H1N1 Flu and Severe Acute Respiratory Syndrome (SARS) infected […]
Thailand confirmed its first case of Middle East Respiratory Syndrome (MERS) on Thursday, becoming the fourth Asian country to register the deadly virus this year. Public Health Minister Rajata Rajatanavin told a news conference that a 75-year-old businessman from Oman had tested positive for MERS. “From two lab tests we can confirm that the MERS […]
South Korea on Wednesday reported eight new cases of Middle East Respiratory Syndrome (MERS), while another person infected with the virus died, health officials said, bringing to 20 the number of fatalities in the outbreak that began last month. A total of 162 people in South Korea have been infected in the outbreak, the largest […]